Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab. Cancer Immunol Res. 2015 May; 3(5):567-74.
View in:
PubMed
subject areas
Adult
Aged
Antibody-Dependent Cell Cytotoxicity
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cell Line, Tumor
Cetuximab
Female
Genotype
Head and Neck Neoplasms
Humans
Kaplan-Meier Estimate
Killer Cells, Natural
Male
Middle Aged
Receptors, IgG
Thalidomide
Treatment Outcome
authors with profiles
Ezra Cohen
Everett E. Vokes